I agree with your very bullish outlook @Tarvold IMHO especially when you look at the range of products NXS already has in the market and the plethora of new products to come. I can see a time when NXS' products will be recognised Worldwide as the Gold standard for treating antibiotic resistant infections and that their products will become a household name like Betadine IMHO DYOR It may take some time, due to the medical profession's rightfully cautious approach to taking up new products but, over time, I believe NXS has significant potential in the long run.
Ann: Investor Presentation, page-11
Add NXS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $58.43M | |||
| Open | High | Low | Value | Volume |
| 20.5¢ | 20.5¢ | 20.0¢ | $42.76K | 213.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 18228 | 20.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.5¢ | 12000 | 1 |
View Market Depth
| Last trade - 16.10pm 29/08/2024 (20 minute delay) ? |
| NXS (ASX) Chart |